Literature DB >> 24129916

[Prevention of psychotic disorders].

J Klosterkötter1.   

Abstract

Psychotic disorders set the first example that prediction and prevention programs of modern medicine can also be successfully applied to central psychiatric disorders. In the last 20 years criteria for the detection of high-risk states prior to the first onset of the disease have been worked out and the predictive power for the transition into psychosis has been confirmed. In the centers for early recognition and prevention, persons seeking help and advice can now be classified into individuals in an early or late high-risk stage by means of newly developed instruments. New possibilities of risk stratification ensure a more individualized selection of appropriate preventive measures. The interventions provided aim at improving risk symptoms, preventing psychosocial disabilities and in particular preventing or at least delaying the onset of psychosis. Proof of efficacy is so far available for newly developed psychotherapeutic methods, neuroprotective agents and low dosage antipsychotics. Prior to administration careful risk-benefit analyses have to be carried out for each individual case.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129916     DOI: 10.1007/s00115-013-3831-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  25 in total

1.  Preventing progression to first-episode psychosis in early initial prodromal states.

Authors:  A Bechdolf; M Wagner; S Ruhrmann; S Harrigan; V Putzfeld; R Pukrop; A Brockhaus-Dumke; J Berning; B Janssen; P Decker; R Bottlender; K Maurer; H-J Möller; W Gaebel; H Häfner; W Maier; J Klosterkötter
Journal:  Br J Psychiatry       Date:  2011-11-10       Impact factor: 9.319

2.  Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.

Authors:  Alison R Yung; Hok Pan Yuen; Patrick D McGorry; Lisa J Phillips; Daniel Kelly; Margaret Dell'Olio; Shona M Francey; Elizabeth M Cosgrave; Eoin Killackey; Carrie Stanford; Katherine Godfrey; Joe Buckby
Journal:  Aust N Z J Psychiatry       Date:  2005 Nov-Dec       Impact factor: 5.744

3.  Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis.

Authors:  Tania Lecomte; Alicia Spidel; Claude Leclerc; G William MacEwan; Caroline Greaves; Richard P Bentall
Journal:  Schizophr Res       Date:  2008-03-04       Impact factor: 4.939

4.  Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk.

Authors:  Paolo Fusar-Poli; Ilaria Bonoldi; Alison R Yung; Stefan Borgwardt; Matthew J Kempton; Lucia Valmaggia; Francesco Barale; Edgardo Caverzasi; Philip McGuire
Journal:  Arch Gen Psychiatry       Date:  2012-03

5.  Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.

Authors:  Andreas Bechdolf; Hendrik Müller; Hartmut Stützer; Michael Wagner; Wolfgang Maier; Marion Lautenschlager; Andreas Heinz; Walter de Millas; Birgit Janssen; Wolfgang Gaebel; Tanja Maria Michel; Frank Schneider; Martin Lambert; Dieter Naber; Martin Brüne; Seza Krüger-Özgürdal; Thomas Wobrock; Michael Riedel; Joachim Klosterkötter
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  The Basel early-detection-of-psychosis (FEPSY)-study--design and preliminary results.

Authors:  A Riecher-Rössler; U Gschwandtner; J Aston; S Borgwardt; M Drewe; P Fuhr; M Pflüger; W Radü; Ch Schindler; R-D Stieglitz
Journal:  Acta Psychiatr Scand       Date:  2007-02       Impact factor: 6.392

Review 7.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

8.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

9.  The ABC Schizophrenia Study: a preliminary overview of the results.

Authors:  H Häfner; K Maurer; W Löffler; W an der Heiden; P Munk-Jørgensen; M Hambrecht; A Riecher-Rössler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-08       Impact factor: 4.328

10.  Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

Authors:  Christos Pantelis; Dennis Velakoulis; Patrick D McGorry; Stephen J Wood; John Suckling; Lisa J Phillips; Alison R Yung; Edward T Bullmore; Warrick Brewer; Bridget Soulsby; Patricia Desmond; Philip K McGuire
Journal:  Lancet       Date:  2003-01-25       Impact factor: 79.321

View more
  2 in total

1.  [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Con].

Authors:  A Bechdolf; S Laier; M Kallenbach; A Biester; K Leopold
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

Review 2.  [Prediction of psychoses].

Authors:  J Klosterkötter
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.